WASHINGTON — Biotech breakthroughs are within U.S. reach, but policy shifts and proposed funding cuts could slow how those advancements reach patients, health organization leaders warned at an April ...
DENVER, Oct. 05, 2026 (GLOBE NEWSWIRE) -- ( 247marketnews.com) -- The biotech market is producing a powerful mix of catalysts, with Alector (NASDAQ: ALEC) and NeOnc Technologies (NASDAQ: NTHI) putting ...
Indiana University awarded funding to six research teams pursuing defense-focused biotechnology projects through the IU ...
The real drug development delay? Bad communication. Biotech is full of brilliant people solving problems most people can barely describe, let alone understand. However, after spending time at BIO2026 ...
Zacks.com on MSN
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Biotech firms have been increasingly directing capital toward oncology therapeutics in recent years, reflecting a structural shift as companies recognize the significant commercial potential of ...
Atomica, a U.S.-based microfabrication foundry, today announced the launch of its Biotechnology Microdevices Platform, the seventh in ...
Over 50 organizations represented, including 40 biotechnology companies More than 5 large pharmaceutical companies and 8 investment firms represented 4 biotech startups pitched their breakthrough ...
VERAXA Biotech (NASDAQ: VRXA), a developer of next-generation antibody-based cancer therapies, provided an update on its ...
Charlotte Owens, M.D., spends a lot of time flying across the country to lead in two very different roles. In South San Francisco, she leads medical affairs at Genentech, which emerged as the world’s ...
ALPS Medical Breakthroughs ETF (SBIO) targets late-stage clinical biotech firms poised for FDA approval or acquisition, offering high-risk, high-reward exposure. SBIO surged 91% over the past year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results